Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 19;28(7):1811-1815.
doi: 10.1021/acs.bioconjchem.7b00224. Epub 2017 Jun 27.

Metabolic Oligosaccharide Engineering with Alkyne Sialic Acids Confers Neuraminidase Resistance and Inhibits Influenza Reproduction

Affiliations

Metabolic Oligosaccharide Engineering with Alkyne Sialic Acids Confers Neuraminidase Resistance and Inhibits Influenza Reproduction

Torben Heise et al. Bioconjug Chem. .

Abstract

Metabolic incorporation of azide- or alkyne-modified sialic acids into the cellular glycosylation pathway enables the study of sialoglycan expression, localization, and trafficking via bioorthogonal chemistry. Herein, we report that such modifications of the sialic acid sugar can have a profound influence on their hydrolysis by neuraminidases (sialidase). Azidoacetyl (Az)-modified sialic acids were prone to neuraminidase cleavage, whereas propargyloxycarbonyl (Poc)-modified sialic acids were largely resistant to cleavage. Because the influenza virus infection cycle depends on the hydrolysis of host-cell-surface sialic acids, influenza cell-to-cell transmission was strongly reduced in Poc sialic acid glycoengineered host cells. The use of Poc sialic acids may disturb biological processes involving neuraminidase cleavage but also provides perspective for use in applications in which sialic acid hydrolysis is not desired, such as antibody modification, viral infection, etc.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Schematic presentation of metabolic labeling with Ac5SiaNAz or Ac5SiaNPoc and the resistance of Ac5SiaNPoc against influenza neuraminidase.
Figure 2
Figure 2
Metabolic labeling of THP-1 cells. (a) The cells were incubated for 3 days with PBS, 100 μM Ac5SiaNAz, or 100 μM Ac5SiaNPoc and reacted to biotin–alkyne or biotin–azide, respectively, using CuAAC. Biotin-containing sialoglycans were stained with PE–streptavidin and visualized by confocal microscopy. (b) Fluorescence was quantified by flow cytometry, and the mean fluorescence intensity ± SEM is shown (n = 3).
Figure 3
Figure 3
Enzymatic removal of Az and Poc sialic acids from the cell surface of THP-1 cells. Cells incubated for 3 days with PBS, 100 μM Ac5SiaNAz, or 100 μM Ac5SiaNPoc were treated for 1 h with 250mU/mL Clostridium perfringens neuraminidase. Az and Poc sialoglycans were reacted to fluorescent biotin using CuAAC (a), α2,3-sialoglycans were detected with MALII lectin (b), α2,6-sialoglycans were detected with SNA-I lectin (c), and terminal β-galactose was detected with PNA lectin (d). Bar diagrams show mean fluorescence intensity or mean lectin binding normalized to control ± SEM of three independent experiments. MALII: Maackia amurensis lectin; PE: phycoerythrin, PNA: Peanut agglutinin lectin; SEM: standard error of the mean; SNA-I: Sambucus nigra lectin.
Figure 4
Figure 4
Effect of Az and Poc sialic acid on influenza reproduction (333× dilution). A549 cells cultured with either Ac5SiaNAz or Ac5SiaNPoc were treated with influenza virus strain A/PR8-GFP/8/34, and the GFP expression was measured as a readout for successful viral infection after 6 h and reinfection after 24 h (a). Az and Poc sialoglycans were detected 24 h post-infection by reaction with fluorescent biotin using the CuAAC (b). Bar diagrams show mean fluorescence intensity ± SEM (n = 4).

Similar articles

Cited by

References

    1. Altheide T. K.; Hayakawa T.; Mikkelsen T. S.; Diaz S.; Varki N.; Varki A. (2006) System-wide Genomic and Biochemical Comparisons of Sialic Acid Biology Among Primates and Rodents: evidence for two modes of rapid evolution. J. Biol. Chem. 281, 25689–25702. 10.1074/jbc.M604221200. - DOI - PubMed
    1. Varki A. (2008) Sialic acids in human health and disease. Trends Mol. Med. 14, 351–360. 10.1016/j.molmed.2008.06.002. - DOI - PMC - PubMed
    1. Dube D. H.; Bertozzi C. R. (2003) Metabolic oligosaccharide engineering as a tool for glycobiology. Curr. Opin. Chem. Biol. 7, 616–625. 10.1016/j.cbpa.2003.08.006. - DOI - PubMed
    1. Cheng B.; Xie R.; Dong L.; Chen X. (2016) Metabolic Remodeling of Cell-Surface Sialic Acids: Principles, Applications, and Recent Advances. ChemBioChem 17, 11–27. 10.1002/cbic.201500344. - DOI - PubMed
    1. Wratil P. R.; Horstkorte R.; Reutter W. (2016) Metabolic Glycoengineering with N-Acyl Side Chain Modified Mannosamines. Angew. Chem., Int. Ed. 55, 9482–9512. 10.1002/anie.201601123. - DOI - PubMed

Publication types

LinkOut - more resources